ABEO - Company ID 0000318306
The table below shows ABEONA THERAPEUTICS INC.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $5.82M | - | $3.50M | $1.41M | $3.00M | $10.00M |
| Cost of revenue | $1.53M | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $26.81M | $34.36M | $31.09M | $28.96M | $38.73M | $30.14M |
| SG&A |
ABEONA THERAPEUTICS INC. reported annual revenue of $5.82M for fiscal year 2025. That is up 66.3% from $3.50M in fiscal 2023. Over the 10 fiscal years shown, annual revenue grew from $925.00K (FY 2014) to $5.82M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $65.03M |
| $29.85M |
| $19.00M |
| $17.26M |
| $21.64M |
| $23.78M |
| Operating income | -$89.45M | -$64.21M | -$47.13M | -$50.91M | -$89.84M | -$81.42M |
| Income tax | $100.00K | - | - | - | - | - |
| Net income | -$71.18M | $63.73M | $54.19M | -$39.70M | -$84.94M | -$84.23M |
| EPS (diluted) | $1.01 | -$1.55 | -$2.53 | -$5.53 | - | - |